In the U.S., many top brand-name drugs continue to get more expensive with age, while the same medicines often get cheaper in peer countries, according to an AARP Public Policy Institute
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Following much opposition from drugmakers, Germany has scrapped its plan to install a program that would have reduced the price…
While dealmaking and investment dollars may be flowing across biopharma once again, acute challenges tied to policy, pricing and…
Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to take matters into its own…
Amid efforts in Germany to retool the country’s drug spending, the U.S. | Amid efforts in Germany to retool the country’s drug…
Even as a new drug pricing specter rears its head in President Donald Trump’s “Most Favored Nation” policies, drugmakers continue…
In an initiative to increase the efficiency of drug manufacturing in the United States, the FDA has
